TRUMY
Terumo Corp Unsponsored ADR (TRUMY) [ST]
▼ 2.38%
prev close
TERUMO CORP UNSP/ADR
Congressional Trades
2
All tracked trades
Members Trading
1
Unique members
Net Activity
-2
0 buys · 2 sells
Members Who Traded This Stock
2 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-07-10 | TRUMYTerumo Corp Unsponsored ADR | Sell | $1,001 - $15,000 | 1074d ago | — | |
| 2023-02-27 | TRUMYTerumo Corp Unsponsored ADR | Sell | $15,001 - $50,000 | 1220d ago | — |
2023-07-10
Daniel Goldman
TRUMY
Amount
$1,001 - $15,000
Filed
1074d ago
2023-02-27
Daniel Goldman
TRUMY
Amount
$15,001 - $50,000
Filed
1220d ago
Recent News
Powered by Polygon.io
[Latest] Global Therapeutic Apheresis Market Size/Share Worth USD 8.94 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Eliaz Therapeutics Launches Reg CF Raise to Advance First Device Targeting Sepsis
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
Patient Blood Management Market Growth Analysis Report 2025-2033 | AI-Driven Analytics Revolutionize Blood Management Strategies, Blockchain Enhances Supply Transparency and Safety
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility
Trade Timeline
Congressional activity, newest first
Daniel Goldman
2023-07-10 · Sale
$1,001 - $15,000
Daniel Goldman
2023-02-27 · Sale
$15,001 - $50,000